arrow_back Back to App

Drug Price Transparency: Ads Must Show Costs

New rules require prescription drug and biological product advertisements to display their prices. This aims to help citizens make informed decisions about purchasing medications and understand their true costs before receiving a prescription. The goal is to increase competition and reduce drug spending.
Key points
Prescription drug advertisements must include the wholesale acquisition cost (WAC) for a 30-day supply or typical course of treatment.
Price information must be presented clearly and conspicuously, regardless of the advertisement medium.
Violators of these rules may face civil penalties of up to $100,000 per violation.
The goal is to increase consumer awareness of drug costs and promote the selection of lower-cost alternatives.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_2304
Sponsor: Sen. Durbin, Richard J. [D-IL]
Process start date: 2021-06-24
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

DTC Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_2304.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-06-24.

What are the main provisions?

Key points include:

  • Prescription drug advertisements must include the wholesale acquisition cost (WAC) for a 30-day supply or typical course of treatment.
  • Price information must be presented clearly and conspicuously, regardless of the advertisement medium.
  • Violators of these rules may face civil penalties of up to $100,000 per violation.
  • The goal is to increase consumer awareness of drug costs and promote the selection of lower-cost alternatives.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Durbin, Richard J. [D-IL].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Economy